KPI Therapeutics Overview
- Year Founded
-
2013

- Status
-
Private
- Latest Deal Type
-
2ndary - Private
KPI Therapeutics General Information
Description
Provider of biotechnology services intended to provide drug development services. The company's biotechnology services focuses on accelerating translational stage, early clinical drug validation process and other clinical drug programs, enabling clients to meet patient needs.
Contact Information
Website
www.kpitherapeutics.com
Formerly Known As
Kineta Prime
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 219 Terry Avenue North
- 4th Floor
- Seattle, WA 98109
- United States
KPI Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
5. Secondary Transaction - Private | 01-Oct-2017 | 000.00 | Completed | Generating Revenue | ||
4. Later Stage VC | 15-May-2017 | 000.00 | Completed | Generating Revenue | ||
3. Later Stage VC (Series C) | 27-May-2015 | 000 | 000.00 | 0000 | Completed | Generating Revenue |
2. Early Stage VC (Series B) | 14-May-2014 | $2.87M | $3.48M | 000.00 | Completed | Generating Revenue |
1. Early Stage VC (Series A) | 13-Sep-2013 | $611K | $611K | 000.00 | Completed | Generating Revenue |
KPI Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A3 | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series A2 | 0,000,000 | 00.000000 | 00.00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
Series A1 | 1,272,915 | $0.000100 | $0.03 | $0.48 | $0.48 | 1x | $0.48 | 2.94% |
KPI Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Provider of biotechnology services intended to provide drug development services. The company's biotechnology services f
Drug Discovery
Seattle, WA
000.00
00000000000
000.00
KPI Therapeutics Competitors (41)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Cyteir Therapeutics | Formerly VC-backed | Lexington, MA | 00 | 00000 | 00000000 | 00000 |
00000 000000000000 | Formerly VC-backed | Waltham, MA | 000 | 00000 | 00000000 | 00000 |
00000000 000000000 | Venture Capital-Backed | Waltham, MA | 00 | 000.00 | 00000000000 | 000.00 |
0000000 0000000000 | Formerly VC-backed | New York, NY | 00 | 00000 | 000000&0 | 00000 |
000000000 | Formerly VC-backed | Gaithersburg, MD | 00 | 00000 | 00000000 | 00000 |